Can acute respiratory distress syndrome be treated?

Affiliations

¹ Department of Medicine, Division of Pulmonary, Critical Care & Sleep Medicine, Ohio State University Wexner Medical Center, Davis Heart & Lung Research Institute, Columbus, OH 43210, USA.
² Department of Chemistry & Biochemistry, The Ohio State University, Columbus, OH 43210, USA.

Editorial

John W Christman et al. Future Med Chem. 2021 Apr.

. 2021 Apr;13(8):687-690.

doi: 10.4155/fmc-2021-0014. Epub 2021 Mar 16.

¹ Department of Medicine, Division of Pulmonary, Critical Care & Sleep Medicine, Ohio State University Wexner Medical Center, Davis Heart & Lung Research Institute, Columbus, OH 43210, USA.
² Department of Chemistry & Biochemistry, The Ohio State University, Columbus, OH 43210, USA.

No abstract available

Keywords: ARDS; COVID-19; calcineurin inhibitors; peptidyl drugs.

References

1. Matthay MA, Zemans RL, Zimmerman GA et al. Acute respiratory distress syndrome. Nat. Rev. Dis. Primers. 5(1), 18 (2019). - PMC - PubMed
1. Tzotzos SJ, Fischer B, Fischer H, Zeitlinger M. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey. Crit. Care 24(1), 516 (2020). - PMC - PubMed
1. Stapleton RD, Suratt BT, Neff MJ et al. Bronchoalveolar fluid and plasma inflammatory biomarkers in contemporary ARDS patients. Biomarkers 24(4), 352–359 (2019). - PMC - PubMed
1. Bendib I, de Chaisemartin L, Mekontso Dessap A, Chollet-Martin S, de Prost N. Understanding the role of neutrophil extracellular traps in patients with severe pneumonia and ARDS. Chest 156(6), 1278–1280 (2019). - PubMed
1. Chen CM, Lu HC, Tung YT, Chen W. Antiplatelet therapy for acute respiratory distress syndrome. Biomedicines 8(7), 230 (2020). - PMC - PubMed